Market Currents
Perrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval...
-
Tuesday, November 27, 2012, 12:50 PM ETPerrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval for its Abbreviated New Drug Application for betamethasone valerate foam, the generic equivalent of Luxiq Foam. Perrigo has manufactured the product and is preparing to begin shipping on January 15, 2013, in line with the launch date.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
